Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

Oncogene

Volumn 30, Issue 3, 2011, Pages 334-345

  Pardali, E ^a   Van Der Schaft, D W J ^b   Wiercinska, E ^a   Gorter, A ^a   Hogendoorn, P C W ^a   Griffioen, A W ^c   Ten Dijke, P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bone morphogenetic proteins; endoglin; Ewing sarcoma; melanoma; transforming growth factor ; tumor cell plasticity

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BETA3 INTEGRIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; ENDOGLIN; FOCAL ADHESION KINASE; INTEGRIN; NOGGIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENICITY; CELL DIFFERENTIATION; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, CELL SURFACE; SARCOMA, EWING'S; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 78751644361     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.418     Document Type: Article

References (44)

1. Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI et al. (1996). Expression and structural features of endoglin (CD105), a transforming growth factor b1 and b3 binding protein, in human melanoma. Br J Cancer 74: 1586-1591.
2. Ben-Haim N, Lu C, Guzman-Ayala M, Pescatore L, Mesnard D, Bischofberger M et al. (2006). The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev Cell 11: 313-323.
3. Bernabeu C, Lopez-Novoa JM, Quintanilla M. (2009). The emerging role of TGF-b superfamily coreceptors in cancer. Biochim Biophys Acta 1792: 954-973.
4. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. (2007). Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109: 1953-1961.
5. Dome B, Raso E, Dobos J, Meszaros L, Varga N, Puskas LG et al. (2005). Parallel expression of aIIbb3 and avb3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype. Int J Cancer 116: 27-35.
6. Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P et al. (2004). CD105 inhibits transforming growth factor-b-Smad3 signalling. Anticancer Res 24: 1337-1345.
7. Hallani SE, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A et al. (2010). A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 133: 973-982.
8. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E et al. (2010). Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70: 4141-4150.
9. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 3: 411-421.
10. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA et al. (2001). Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 98: 8018-8023.
11. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. (2007). Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255.
12. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ et al. (2002). Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62: 665-668.
13. Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE et al. (2005). Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res 65: 9851-9860.
14. Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, Seftor RE et al. (2001). Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 61: 3250-3255.
15. Hess AR, Seftor EA, Seftor RE, Hendrix MJ. (2003). Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63: 4757-4762.
16. Hillen F, Kaijzel EL, Castermans K, oude Egbrink MG, Lowik CW, Griffioen AW. (2008). A transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors. Biochem Biophys Res Commun 368: 364-367.
17. Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K et al. (2006). Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci 47: 802-806.
18. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M et al. (2004). Endoglin promotes endothelial cell proliferation and TGF-b/ALK1 signal transduction. EMBO J 23: 4018-4028.
19. Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC. (2002). Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 21: 8272-8281.
20. 0er J et al. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752.
21. Medrano EE. (2003). Repression of TGF-b signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 22: 3123-3129.
22. Mueller AJ, Bartsch DU, Folberg R, Mehaffey MG, Boldt HC, Meyer M et al. (1998). Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 116: 31-39.
23. Ottaviano L, Schaefer KL, Gajewski M, Huckenbeck W, Baldus S, Rogel U et al. (2010). Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer 49: 40-51.
24. Oxmann D, Held-Feindt J, Stark AM, Hattermann K, Yoneda T, Mentlein R. (2008). Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype. Oncogene 27: 3567-3575.
25. Perez-Gomez E, Villa-Morales M, Santos J, Fernandez-Piqueras J, Gamallo C, Dotor J et al. (2007). A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis. Cancer Res 67: 10268-10277.
26. Rothhammer T, Bataille F, Spruss T, Eissner G, Bosserhoff AK. (2007). Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26: 4158-4170.
27. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. (2005). Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65: 448-456.
28. Scavelli C, Nico B, Cirulli T, Ria R, Di PG, Mangieri D et al. (2008). Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 27: 663-674. (Pubitemid 351158901)
29. 0er J, Maniotis AJ, Trent JM et al. (2002). Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19: 233-246.
30. Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M. (1997). Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res 3: 1031-1044.
31. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger Jr PM, Cohen MB et al. (2002). Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculo-genic mimicry. Prostate 50: 189-201.
32. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K et al. (2002). Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99: 821-828.
33. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE et al. (2001). Molecular determinants of ovarian cancer plasticity. Am J Pathol 158: 1279-1288.
34. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G et al. (2004). DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64: 8213-8221.
35. Sun B, Zhang S, Zhang D, Gu Y, Zhang W, Zhao X. (2007). The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model. J Cancer Res Clin Oncol 133: 979-985.
36. Szuhai K, Ijszenga M, Tanke HJ, Rosenberg C, Hogendoorn PC. (2006). Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet 166: 173-179.
37. Ten Dijke P, Arthur HM (2007). Extracellular control of TGFb signalling in vascular development and disease. Nat Rev Mol Cell Biol, 8, 857-869.
38. ten Dijke P, Goumans MJ, Pardali E. (2008). Endoglin in angiogenesis and vascular diseases. Angiogenesis 11: 79-89.
39. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925-932.
40. Van der Schaft DW, Hillen F, Pauwels P, Kirschmann DA, Caster-mans K, Egbrink MG et al. (2005). Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65: 11520-11528.
41. Van der Schaft DW, Seftor RE, Seftor EA, Hess AR, Gruman LM, Kirschmann DA et al. (2004). Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 96: 1473-1477.
42. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM et al. (2006). Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649. (Pubitemid 43865232)
43. Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL et al. (2008). Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer 123: 2816-2823.
44. Zhou Y, Dai DL, Martinka M, Su M, Zhang Y, Campos EI et al. (2005). Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 124: 1044-1052.